High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study Article Swipe
Tessa G. Steenbruggen
,
Lars C. Steggink
,
Caroline Seynaeve
,
Jacobus J. M. van der Hoeven
,
Maartje J. Hooning
,
Agnes Jager
,
Inge R. Konings
,
Judith R. Kroep
,
Willem M. Smit
,
Vivianne C. G. Tjan‐Heijnen
,
Elsken van der Wall
,
Adriaan D. Bins
,
Sabine C. Linn
,
Michael Schaapveld
,
Flora E. van Leeuwen
,
Carolina P. Schröder
,
Harm van Tinteren
,
Elisabeth G.E. de Vries
,
Gabe S. Sonke
,
Jourik A. Gietema
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1093/annonc/mdy270.184
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1093/annonc/mdy270.184
Related Topics
Concepts
Medicine
Epirubicin
Carboplatin
ThioTEPA
Cyclophosphamide
Internal medicine
Randomized controlled trial
Chemotherapy
Oncology
Surgery
Breast cancer
Cancer
Cisplatin
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/annonc/mdy270.184
- https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy270.184/26141203/mdy270.184.pdf
- OA Status
- hybrid
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2898244900
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2898244900Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/annonc/mdy270.184Digital Object Identifier
- Title
-
High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 studyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-10-01Full publication date if available
- Authors
-
Tessa G. Steenbruggen, Lars C. Steggink, Caroline Seynaeve, Jacobus J. M. van der Hoeven, Maartje J. Hooning, Agnes Jager, Inge R. Konings, Judith R. Kroep, Willem M. Smit, Vivianne C. G. Tjan‐Heijnen, Elsken van der Wall, Adriaan D. Bins, Sabine C. Linn, Michael Schaapveld, Flora E. van Leeuwen, Carolina P. Schröder, Harm van Tinteren, Elisabeth G.E. de Vries, Gabe S. Sonke, Jourik A. GietemaList of authors in order
- Landing page
-
https://doi.org/10.1093/annonc/mdy270.184Publisher landing page
- PDF URL
-
https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy270.184/26141203/mdy270.184.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy270.184/26141203/mdy270.184.pdfDirect OA link when available
- Concepts
-
Medicine, Epirubicin, Carboplatin, ThioTEPA, Cyclophosphamide, Internal medicine, Randomized controlled trial, Chemotherapy, Oncology, Surgery, Breast cancer, Cancer, CisplatinTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2898244900 |
|---|---|
| doi | https://doi.org/10.1093/annonc/mdy270.184 |
| ids.doi | https://doi.org/10.1093/annonc/mdy270.184 |
| ids.mag | 2898244900 |
| ids.openalex | https://openalex.org/W2898244900 |
| fwci | 0.0 |
| type | article |
| title | High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study |
| biblio.issue | |
| biblio.volume | 29 |
| biblio.last_page | viii59 |
| biblio.first_page | viii59 |
| topics[0].id | https://openalex.org/T10183 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9986000061035156 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1306 |
| topics[0].subfield.display_name | Cancer Research |
| topics[0].display_name | Breast Cancer Treatment Studies |
| topics[1].id | https://openalex.org/T11752 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9937999844551086 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Treatment and Pharmacology |
| topics[2].id | https://openalex.org/T11287 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9864000082015991 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1306 |
| topics[2].subfield.display_name | Cancer Research |
| topics[2].display_name | Cancer Genomics and Diagnostics |
| is_xpac | False |
| apc_list.value | 4060 |
| apc_list.currency | USD |
| apc_list.value_usd | 4060 |
| apc_paid.value | 4060 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4060 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9336332082748413 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780835546 |
| concepts[1].level | 4 |
| concepts[1].score | 0.671567976474762 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q425122 |
| concepts[1].display_name | Epirubicin |
| concepts[2].id | https://openalex.org/C2781451048 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6679370999336243 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q415588 |
| concepts[2].display_name | Carboplatin |
| concepts[3].id | https://openalex.org/C2779968505 |
| concepts[3].level | 4 |
| concepts[3].score | 0.5992709994316101 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q416507 |
| concepts[3].display_name | ThioTEPA |
| concepts[4].id | https://openalex.org/C2776755627 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5263931751251221 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q408524 |
| concepts[4].display_name | Cyclophosphamide |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5156353712081909 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C168563851 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4922555983066559 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[6].display_name | Randomized controlled trial |
| concepts[7].id | https://openalex.org/C2776694085 |
| concepts[7].level | 2 |
| concepts[7].score | 0.48690998554229736 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[7].display_name | Chemotherapy |
| concepts[8].id | https://openalex.org/C143998085 |
| concepts[8].level | 1 |
| concepts[8].score | 0.46185266971588135 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[8].display_name | Oncology |
| concepts[9].id | https://openalex.org/C141071460 |
| concepts[9].level | 1 |
| concepts[9].score | 0.4521799087524414 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[9].display_name | Surgery |
| concepts[10].id | https://openalex.org/C530470458 |
| concepts[10].level | 3 |
| concepts[10].score | 0.411260724067688 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[10].display_name | Breast cancer |
| concepts[11].id | https://openalex.org/C121608353 |
| concepts[11].level | 2 |
| concepts[11].score | 0.26025980710983276 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[11].display_name | Cancer |
| concepts[12].id | https://openalex.org/C2778239845 |
| concepts[12].level | 3 |
| concepts[12].score | 0.197037935256958 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q412415 |
| concepts[12].display_name | Cisplatin |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9336332082748413 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/epirubicin |
| keywords[1].score | 0.671567976474762 |
| keywords[1].display_name | Epirubicin |
| keywords[2].id | https://openalex.org/keywords/carboplatin |
| keywords[2].score | 0.6679370999336243 |
| keywords[2].display_name | Carboplatin |
| keywords[3].id | https://openalex.org/keywords/thiotepa |
| keywords[3].score | 0.5992709994316101 |
| keywords[3].display_name | ThioTEPA |
| keywords[4].id | https://openalex.org/keywords/cyclophosphamide |
| keywords[4].score | 0.5263931751251221 |
| keywords[4].display_name | Cyclophosphamide |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.5156353712081909 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[6].score | 0.4922555983066559 |
| keywords[6].display_name | Randomized controlled trial |
| keywords[7].id | https://openalex.org/keywords/chemotherapy |
| keywords[7].score | 0.48690998554229736 |
| keywords[7].display_name | Chemotherapy |
| keywords[8].id | https://openalex.org/keywords/oncology |
| keywords[8].score | 0.46185266971588135 |
| keywords[8].display_name | Oncology |
| keywords[9].id | https://openalex.org/keywords/surgery |
| keywords[9].score | 0.4521799087524414 |
| keywords[9].display_name | Surgery |
| keywords[10].id | https://openalex.org/keywords/breast-cancer |
| keywords[10].score | 0.411260724067688 |
| keywords[10].display_name | Breast cancer |
| keywords[11].id | https://openalex.org/keywords/cancer |
| keywords[11].score | 0.26025980710983276 |
| keywords[11].display_name | Cancer |
| keywords[12].id | https://openalex.org/keywords/cisplatin |
| keywords[12].score | 0.197037935256958 |
| keywords[12].display_name | Cisplatin |
| language | en |
| locations[0].id | doi:10.1093/annonc/mdy270.184 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S41454044 |
| locations[0].source.issn | 0923-7534, 1569-8041 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0923-7534 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Annals of Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy270.184/26141203/mdy270.184.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Annals of Oncology |
| locations[0].landing_page_url | https://doi.org/10.1093/annonc/mdy270.184 |
| locations[1].id | pmh:vumc:oai:pure.atira.dk:publications/a1f8b148-e4f8-4462-bf7a-3bd1f4459c30 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306401843 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | Data Archiving and Networked Services (DANS) |
| locations[1].source.host_organization | https://openalex.org/I1322597698 |
| locations[1].source.host_organization_name | Royal Netherlands Academy of Arts and Sciences |
| locations[1].source.host_organization_lineage | https://openalex.org/I1322597698 |
| locations[1].license | other-oa |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | info:eu-repo/semantics/article |
| locations[1].license_id | https://openalex.org/licenses/other-oa |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Annals of oncology : official journal of the European Society for Medical Oncology, 29. Oxford University Press |
| locations[1].landing_page_url | https://research.vumc.nl/en/publications/a1f8b148-e4f8-4462-bf7a-3bd1f4459c30 |
| locations[2].id | pmh:amcpub:oai:pure.amc.nl:publications/48375c49-58ae-4770-90df-8687f72b3af1 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401843 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Data Archiving and Networked Services (DANS) |
| locations[2].source.host_organization | https://openalex.org/I1322597698 |
| locations[2].source.host_organization_name | Royal Netherlands Academy of Arts and Sciences |
| locations[2].source.host_organization_lineage | https://openalex.org/I1322597698 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | info:eu-repo/semantics/article |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Annals of oncology, 29. Oxford University Press |
| locations[2].landing_page_url | https://pure.amc.nl/en/publications/highdose-chemotherapy-hdct-with-hematopoietic-stem-cell-transplantation-hsct-in-highrisk-breast-cancer-bc-patients-with-4-involved-axillary-lymph-nodes-aln-20year-followup-of-a-randomized-phase-3-study(48375c49-58ae-4770-90df-8687f72b3af1).html |
| locations[3].id | pmh:eur:oai:repub.eur.nl:125530 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306401843 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Data Archiving and Networked Services (DANS) |
| locations[3].source.host_organization | https://openalex.org/I1322597698 |
| locations[3].source.host_organization_name | Royal Netherlands Academy of Arts and Sciences |
| locations[3].source.host_organization_lineage | https://openalex.org/I1322597698 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | info:eu-repo/semantics/article |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Annals of Oncology, 29 |
| locations[3].landing_page_url | http://hdl.handle.net/1765/125530 |
| locations[4].id | pmh:oai:repub.eur.nl:125530 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S4306400997 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | RePub (Erasmus University, Rotterdam) |
| locations[4].source.host_organization | https://openalex.org/I913958620 |
| locations[4].source.host_organization_name | Erasmus University Rotterdam |
| locations[4].source.host_organization_lineage | https://openalex.org/I913958620 |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | info:eu-repo/semantics/article |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Annals of Oncology vol. 29 |
| locations[4].landing_page_url | http://repub.eur.nl/pub/125530 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5017612284 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6870-5785 |
| authorships[0].author.display_name | Tessa G. Steenbruggen |
| authorships[0].countries | NL |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2898336195 |
| authorships[0].affiliations[0].raw_affiliation_string | Medical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands |
| authorships[0].institutions[0].id | https://openalex.org/I2898336195 |
| authorships[0].institutions[0].ror | https://ror.org/03xqtf034 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I2898336195 |
| authorships[0].institutions[0].country_code | NL |
| authorships[0].institutions[0].display_name | The Netherlands Cancer Institute |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | T.G. Steenbruggen |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Medical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands |
| authorships[1].author.id | https://openalex.org/A5027797733 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8955-8702 |
| authorships[1].author.display_name | Lars C. Steggink |
| authorships[1].countries | NL |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1334415907 |
| authorships[1].affiliations[0].raw_affiliation_string | Medical Oncology, University Medical Center Groningen, Groningen, Netherlands |
| authorships[1].institutions[0].id | https://openalex.org/I1334415907 |
| authorships[1].institutions[0].ror | https://ror.org/03cv38k47 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I1334415907 |
| authorships[1].institutions[0].country_code | NL |
| authorships[1].institutions[0].display_name | University Medical Center Groningen |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | L.C. Steggink |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Medical Oncology, University Medical Center Groningen, Groningen, Netherlands |
| authorships[2].author.id | https://openalex.org/A5105781867 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Caroline Seynaeve |
| authorships[2].countries | NL |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210149908 |
| authorships[2].affiliations[0].raw_affiliation_string | Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, Netherlands |
| authorships[2].institutions[0].id | https://openalex.org/I4210149908 |
| authorships[2].institutions[0].ror | https://ror.org/03r4m3349 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I2801952686, https://openalex.org/I4210149908 |
| authorships[2].institutions[0].country_code | NL |
| authorships[2].institutions[0].display_name | Erasmus MC Cancer Institute |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | C.M. Seynaeve |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, Netherlands |
| authorships[3].author.id | https://openalex.org/A5049513985 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1117-1959 |
| authorships[3].author.display_name | Jacobus J. M. van der Hoeven |
| authorships[3].countries | NL |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I145872427 |
| authorships[3].affiliations[0].raw_affiliation_string | Medical Oncology, Radboud University, Nijmegen, Netherlands |
| authorships[3].institutions[0].id | https://openalex.org/I145872427 |
| authorships[3].institutions[0].ror | https://ror.org/016xsfp80 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I145872427 |
| authorships[3].institutions[0].country_code | NL |
| authorships[3].institutions[0].display_name | Radboud University Nijmegen |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | J.J.M. van der Hoeven |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Medical Oncology, Radboud University, Nijmegen, Netherlands |
| authorships[4].author.id | https://openalex.org/A5071754639 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-6763-0857 |
| authorships[4].author.display_name | Maartje J. Hooning |
| authorships[4].countries | NL |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210149908 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, Netherlands |
| authorships[4].institutions[0].id | https://openalex.org/I4210149908 |
| authorships[4].institutions[0].ror | https://ror.org/03r4m3349 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I2801952686, https://openalex.org/I4210149908 |
| authorships[4].institutions[0].country_code | NL |
| authorships[4].institutions[0].display_name | Erasmus MC Cancer Institute |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | M.J. Hooning |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, Netherlands |
| authorships[5].author.id | https://openalex.org/A5064453966 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-7713-1450 |
| authorships[5].author.display_name | Agnes Jager |
| authorships[5].countries | NL |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210149908 |
| authorships[5].affiliations[0].raw_affiliation_string | Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, Netherlands |
| authorships[5].institutions[0].id | https://openalex.org/I4210149908 |
| authorships[5].institutions[0].ror | https://ror.org/03r4m3349 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2801952686, https://openalex.org/I4210149908 |
| authorships[5].institutions[0].country_code | NL |
| authorships[5].institutions[0].display_name | Erasmus MC Cancer Institute |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | A. Jager |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, Netherlands |
| authorships[6].author.id | https://openalex.org/A5103026138 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-2798-704X |
| authorships[6].author.display_name | Inge R. Konings |
| authorships[6].affiliations[0].raw_affiliation_string | Medical Oncology, Vrije University Medical Centre (VUMC), Amsterdam, Netherlands |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | I.R. Konings |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Medical Oncology, Vrije University Medical Centre (VUMC), Amsterdam, Netherlands |
| authorships[7].author.id | https://openalex.org/A5021122880 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2671-1903 |
| authorships[7].author.display_name | Judith R. Kroep |
| authorships[7].countries | NL |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I2800006345 |
| authorships[7].affiliations[0].raw_affiliation_string | Medical Oncology, Leiden University Medical Center (LUMC), Leiden, Netherlands |
| authorships[7].institutions[0].id | https://openalex.org/I2800006345 |
| authorships[7].institutions[0].ror | https://ror.org/05xvt9f17 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I2800006345 |
| authorships[7].institutions[0].country_code | NL |
| authorships[7].institutions[0].display_name | Leiden University Medical Center |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | J.R. Kroep |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Medical Oncology, Leiden University Medical Center (LUMC), Leiden, Netherlands |
| authorships[8].author.id | https://openalex.org/A5050032230 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Willem M. Smit |
| authorships[8].countries | NL |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2801766299 |
| authorships[8].affiliations[0].raw_affiliation_string | Medical Oncology, Medisch Spectrum Twente (MST), Enschede, Netherlands |
| authorships[8].institutions[0].id | https://openalex.org/I2801766299 |
| authorships[8].institutions[0].ror | https://ror.org/033xvax87 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I2801766299 |
| authorships[8].institutions[0].country_code | NL |
| authorships[8].institutions[0].display_name | Medisch Spectrum Twente |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | W.M. Smit |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Medical Oncology, Medisch Spectrum Twente (MST), Enschede, Netherlands |
| authorships[9].author.id | https://openalex.org/A5054754505 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-3935-7440 |
| authorships[9].author.display_name | Vivianne C. G. Tjan‐Heijnen |
| authorships[9].countries | NL |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I34352273 |
| authorships[9].affiliations[0].raw_affiliation_string | Medical Oncology, Maastricht University Medical Center (MUMC), Maastricht, Netherlands |
| authorships[9].institutions[0].id | https://openalex.org/I34352273 |
| authorships[9].institutions[0].ror | https://ror.org/02jz4aj89 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I34352273 |
| authorships[9].institutions[0].country_code | NL |
| authorships[9].institutions[0].display_name | Maastricht University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | V.C.G. Tjan-Heijnen |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Medical Oncology, Maastricht University Medical Center (MUMC), Maastricht, Netherlands |
| authorships[10].author.id | https://openalex.org/A5090786009 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-2568-6937 |
| authorships[10].author.display_name | Elsken van der Wall |
| authorships[10].countries | NL |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I3018483916 |
| authorships[10].affiliations[0].raw_affiliation_string | Cancer Center, UMC - University Medical Center Utrecht, Utrecht, Netherlands |
| authorships[10].institutions[0].id | https://openalex.org/I3018483916 |
| authorships[10].institutions[0].ror | https://ror.org/0575yy874 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I3018483916 |
| authorships[10].institutions[0].country_code | NL |
| authorships[10].institutions[0].display_name | University Medical Center Utrecht |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | E. van der Wall |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Cancer Center, UMC - University Medical Center Utrecht, Utrecht, Netherlands |
| authorships[11].author.id | https://openalex.org/A5000857797 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-9794-6526 |
| authorships[11].author.display_name | Adriaan D. Bins |
| authorships[11].countries | NL |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I2802928900 |
| authorships[11].affiliations[0].raw_affiliation_string | Medical Oncology, Academic Medical Center (AMC), Amsterdam, Netherlands |
| authorships[11].institutions[0].id | https://openalex.org/I2802928900 |
| authorships[11].institutions[0].ror | https://ror.org/03t4gr691 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I2802928900, https://openalex.org/I4210151833 |
| authorships[11].institutions[0].country_code | NL |
| authorships[11].institutions[0].display_name | Amsterdam UMC Location University of Amsterdam |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | A.D. Bins |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Medical Oncology, Academic Medical Center (AMC), Amsterdam, Netherlands |
| authorships[12].author.id | https://openalex.org/A5063917865 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5541-0347 |
| authorships[12].author.display_name | Sabine C. Linn |
| authorships[12].countries | NL |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I2898336195 |
| authorships[12].affiliations[0].raw_affiliation_string | Medical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands |
| authorships[12].institutions[0].id | https://openalex.org/I2898336195 |
| authorships[12].institutions[0].ror | https://ror.org/03xqtf034 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I2898336195 |
| authorships[12].institutions[0].country_code | NL |
| authorships[12].institutions[0].display_name | The Netherlands Cancer Institute |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | S.C. Linn |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Medical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands |
| authorships[13].author.id | https://openalex.org/A5012843588 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-4390-7182 |
| authorships[13].author.display_name | Michael Schaapveld |
| authorships[13].countries | NL |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I2898336195 |
| authorships[13].affiliations[0].raw_affiliation_string | Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek hospital (NKI-AVL), Amsterdam, Netherlands |
| authorships[13].institutions[0].id | https://openalex.org/I2898336195 |
| authorships[13].institutions[0].ror | https://ror.org/03xqtf034 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I2898336195 |
| authorships[13].institutions[0].country_code | NL |
| authorships[13].institutions[0].display_name | The Netherlands Cancer Institute |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | M. Schaapveld |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek hospital (NKI-AVL), Amsterdam, Netherlands |
| authorships[14].author.id | https://openalex.org/A5030601121 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-5871-1484 |
| authorships[14].author.display_name | Flora E. van Leeuwen |
| authorships[14].countries | NL |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I2898336195 |
| authorships[14].affiliations[0].raw_affiliation_string | Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek hospital (NKI-AVL), Amsterdam, Netherlands |
| authorships[14].institutions[0].id | https://openalex.org/I2898336195 |
| authorships[14].institutions[0].ror | https://ror.org/03xqtf034 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I2898336195 |
| authorships[14].institutions[0].country_code | NL |
| authorships[14].institutions[0].display_name | The Netherlands Cancer Institute |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | F.E. van Leeuwen |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek hospital (NKI-AVL), Amsterdam, Netherlands |
| authorships[15].author.id | https://openalex.org/A5083485582 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-7537-489X |
| authorships[15].author.display_name | Carolina P. Schröder |
| authorships[15].countries | NL |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I1334415907 |
| authorships[15].affiliations[0].raw_affiliation_string | Medical Oncology, University Medical Center Groningen, Groningen, Netherlands |
| authorships[15].institutions[0].id | https://openalex.org/I1334415907 |
| authorships[15].institutions[0].ror | https://ror.org/03cv38k47 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I1334415907 |
| authorships[15].institutions[0].country_code | NL |
| authorships[15].institutions[0].display_name | University Medical Center Groningen |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | C.P. Schroder |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Medical Oncology, University Medical Center Groningen, Groningen, Netherlands |
| authorships[16].author.id | https://openalex.org/A5031176507 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-4626-8702 |
| authorships[16].author.display_name | Harm van Tinteren |
| authorships[16].countries | NL |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I2898336195 |
| authorships[16].affiliations[0].raw_affiliation_string | Biostatistics, Het Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, Netherlands |
| authorships[16].institutions[0].id | https://openalex.org/I2898336195 |
| authorships[16].institutions[0].ror | https://ror.org/03xqtf034 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I2898336195 |
| authorships[16].institutions[0].country_code | NL |
| authorships[16].institutions[0].display_name | The Netherlands Cancer Institute |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | H. van Tinteren |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Biostatistics, Het Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, Netherlands |
| authorships[17].author.id | https://openalex.org/A5061495577 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-8949-7425 |
| authorships[17].author.display_name | Elisabeth G.E. de Vries |
| authorships[17].countries | NL |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I1334415907 |
| authorships[17].affiliations[0].raw_affiliation_string | Medical Oncology, University Medical Center Groningen, Groningen, Netherlands |
| authorships[17].institutions[0].id | https://openalex.org/I1334415907 |
| authorships[17].institutions[0].ror | https://ror.org/03cv38k47 |
| authorships[17].institutions[0].type | healthcare |
| authorships[17].institutions[0].lineage | https://openalex.org/I1334415907 |
| authorships[17].institutions[0].country_code | NL |
| authorships[17].institutions[0].display_name | University Medical Center Groningen |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | E.G.E. de Vries |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Medical Oncology, University Medical Center Groningen, Groningen, Netherlands |
| authorships[18].author.id | https://openalex.org/A5048535376 |
| authorships[18].author.orcid | https://orcid.org/0000-0001-8088-9628 |
| authorships[18].author.display_name | Gabe S. Sonke |
| authorships[18].countries | NL |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I2898336195 |
| authorships[18].affiliations[0].raw_affiliation_string | Medical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands |
| authorships[18].institutions[0].id | https://openalex.org/I2898336195 |
| authorships[18].institutions[0].ror | https://ror.org/03xqtf034 |
| authorships[18].institutions[0].type | healthcare |
| authorships[18].institutions[0].lineage | https://openalex.org/I2898336195 |
| authorships[18].institutions[0].country_code | NL |
| authorships[18].institutions[0].display_name | The Netherlands Cancer Institute |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | G.S. Sonke |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Medical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands |
| authorships[19].author.id | https://openalex.org/A5047685910 |
| authorships[19].author.orcid | https://orcid.org/0000-0003-0629-7354 |
| authorships[19].author.display_name | Jourik A. Gietema |
| authorships[19].countries | NL |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I1334415907 |
| authorships[19].affiliations[0].raw_affiliation_string | Medical Oncology, University Medical Center Groningen, Groningen, Netherlands |
| authorships[19].institutions[0].id | https://openalex.org/I1334415907 |
| authorships[19].institutions[0].ror | https://ror.org/03cv38k47 |
| authorships[19].institutions[0].type | healthcare |
| authorships[19].institutions[0].lineage | https://openalex.org/I1334415907 |
| authorships[19].institutions[0].country_code | NL |
| authorships[19].institutions[0].display_name | University Medical Center Groningen |
| authorships[19].author_position | last |
| authorships[19].raw_author_name | J.A. Gietema |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Medical Oncology, University Medical Center Groningen, Groningen, Netherlands |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy270.184/26141203/mdy270.184.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10183 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9986000061035156 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1306 |
| primary_topic.subfield.display_name | Cancer Research |
| primary_topic.display_name | Breast Cancer Treatment Studies |
| related_works | https://openalex.org/W579378004, https://openalex.org/W4244617181, https://openalex.org/W2397146001, https://openalex.org/W4235863775, https://openalex.org/W2892057079, https://openalex.org/W193298332, https://openalex.org/W1994661110, https://openalex.org/W2418744057, https://openalex.org/W2010256259, https://openalex.org/W2411938410 |
| cited_by_count | 0 |
| locations_count | 5 |
| best_oa_location.id | doi:10.1093/annonc/mdy270.184 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S41454044 |
| best_oa_location.source.issn | 0923-7534, 1569-8041 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0923-7534 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Annals of Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy270.184/26141203/mdy270.184.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Annals of Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1093/annonc/mdy270.184 |
| primary_location.id | doi:10.1093/annonc/mdy270.184 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S41454044 |
| primary_location.source.issn | 0923-7534, 1569-8041 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0923-7534 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Annals of Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy270.184/26141203/mdy270.184.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Annals of Oncology |
| primary_location.landing_page_url | https://doi.org/10.1093/annonc/mdy270.184 |
| publication_date | 2018-10-01 |
| publication_year | 2018 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 20 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8500000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.14397619 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |